Mounjaro 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV786
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,095
Award facts
- Contract value 100% obligated
- $10,094.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerSourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 23, 2026, for $10,094.67 to supply Mounjaro 10 mg/0.5 mL pen injections. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 26, 2026, and represents a task order under AmerSourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The parent company, Cencora, Inc. (doing business as AmerSourceBergen), holds a substantial IDC valued at $999,999,999.00 through December 2031 that serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide.
This delivery order exemplifies AmerSourceBergen's role as a critical vendor in the federal medical supply chain, demonstrating the company's capability to fulfill competitive procurement requirements for pharmaceutical products across multiple therapeutic domains. The Defense Logistics Agency utilizes such delivery orders to obtain essential medications from pre-established indefinite delivery contracts, allowing for efficient procurement of pharmaceuticals needed by military treatment facilities, the Defense Health Agency, and other federal healthcare systems. The non-set-aside designation indicates this award was made through full and open competition, reflecting AmerSourceBergen's established capability to meet federal procurement standards for pharmaceutical distribution.
Quick answers
Who was awarded contract SPE2DR26FV786?
SPE2DR26FV786 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FV786 worth?
The government has obligated $10,095 on SPE2DR26FV786.
Is contract SPE2DR26FV786 an order under another contract?
Yes. SPE2DR26FV786 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV786 competed?
The extent of competition for SPE2DR26FV786 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award